NOBELPHARMA
Nobelpharma was founded in 2003, and in 2008 we obtained our first marketing approval for an ethical drug, NOBELZIN®. We now have marketing approvals for and sell 18 new drugs and one new medical device. In the pharmaceuticals industry, there are no companies of similar scale and age launching as many new drugs as we have. It is the pursuit of our unique product planning and research and development that has led to this achievement. We engage in the projects of "drugs and medical devices for un... met medical needs" which are critical but neglected. We chose not to carry out the time-consuming and costly basic researches. Instead, we conduct license negotiations and research activities focusing on patient needs and select the best possible candidates (new drug candidates) from outside our company. This is because we want to deliver the drugs and medical devices for unmet medical needs to the medical front as quickly as possible, for the benefit of the patients. Unique management strategy for
NOBELPHARMA
Founded:
2003-01-01
Status:
Active
Contact:
0120-003-140
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Apache Microsoft Exchange Online Amazon
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-27 | VLP Therapeutics | Nobelpharma investment in Series A - VLP Therapeutics | 21 M USD |